Brazil Biomaterials in Healthcare Market Report 2022 to 2030

Brazil Biomaterials in Healthcare Market Analysis

$ 3999

Brazil's Biomaterials in Healthcare Market is expected to witness growth from $3.90 Bn in 2022 to $11.30 Bn in 2030 with a CAGR of 14.20% for the forecasted year 2022-30. The increasing incidence of periodontal disease, tooth decay, oral cancer, halitosis, and dental caries in Brazil is driving demand for biomaterials, which is expected to propel growth in the Brazilian biomaterial healthcare market. The market is segmented by type and by application. Some key players in this market include Baumer SA, Injex Surgical Industries, FGM Products Odontologicos, BASF SE, Johnson and Johnson, Medtronic, and Evonik Industries.

ID: IN10BRMD003 CATEGORY: Medical Devices GEOGRAPHY: Brazil AUTHOR: Jigyasu Bhandari

Buy Now

Brazil Biomaterials in Healthcare Market Executive Analysis

Brazil's Biomaterials in Healthcare Market is expected to witness growth from $3.90 Bn in 2022 to $11.30 Bn in 2030 with a CAGR of 14.20% for the forecasted year 2022-30. From 9.46% in 2018 to 9.59% in 2019, Brazil's present health expenditures increased (as a percentage of GDP). Brazil will spend 12.6% of its GDP on health by 2040, with room for growth in areas such as basic care, hospital care, medications, long-term care, and administration. Brazil has a 72.5-year male life expectancy and a 79.5-year female life expectancy. Population growth in Brazil is 0.7% yearly.

In Brazil, Biomaterials have recently grown in significance within the Brazilian healthcare industry. Biomaterials are substances created with the intention of interacting with biological systems to enhance health results. These materials are used in a variety of healthcare applications, including drug delivery devices and medical implants. Numerous medical implants, such as orthopedic implants, tooth implants, and cardiovascular implants, are made from biomaterials. Dressings and other wound care items are made from biomaterials to encourage healing and lower the risk of infection. To build scaffolds for tissue engineering, which can be used to produce replacement organs and tissues, biomaterials are used. The efficacy of treatments is increased by using biomaterials to build drug delivery devices that can release drugs over a predetermined time period. Diagnostic tools that can swiftly and precisely identify diseases and other health conditions, like lab-on-a-chip systems and biosensors, use biomaterials as their building blocks.

brazil-biomaterials-in-healthcare-market

Market Dynamics

Market Growth Drivers

The increasing incidence of periodontal disease, tooth decay, oral cancer, halitosis, and dental caries in Brazil is driving demand for biomaterials, which is expected to propel growth in the Brazil biomaterial healthcare market. Metals, polymers, ceramics, and alloys are examples of biomaterials. Patients and healthcare professionals are becoming more aware of the benefits of using nanomaterials in medicine. As more people become aware of these things, demand will undoubtedly continue to rise. Brazil's ageing population is driving up demand for biomaterials to treat age-related diseases like osteoarthritis, spinal issues, and cardiovascular disease. Demand for biomaterials is rising as more patients and health workers are informed of their advantages. The demand for biomaterials used in medical treatments like cosmetic surgery and dental implants is increasing in Brazil as a result of the country's expanding medical tourism sector.

Market Restraints

Many businesses are vying for market dominance in Brazil's fiercely competitive biomaterials business. Price volatility could result from this, which would reduce the profitability of production firms. Due to the high cost of biomaterial manufacturing, it might be challenging for new biomaterials companies in Brazil to enter the healthcare biomaterials market. Ethical issues may limit the use of biomaterials in certain situations, such as stem cell studies and tissue engineering.

Competitive Landscape

Key Players

Baumer SA (BR)
Injex Surgical Industries (BR)
FGM Products Odontologicos (BR)
BASF SE
Johnson and Johnson
Medtronic
Evonik Industries

Healthcare Policies and Regulatory Landscape

The Brazilian government's regulating body in charge of approving and supervising the use of medical devices and biomaterials is the National Health Surveillance Agency (ANVISA). ANVISA sets the standards for these goods' efficacy and safety and manages the registration procedure for businesses wishing to sell them in Brazil. In Brazil, intellectual property is registered and protected by the National Institute of Industrial Property (INPI). To secure their innovations, companies creating new biomaterials must apply for INPI patents. Brazil's national healthcare system, the Unified Health System (SHS), offers its citizens free or inexpensive medical treatment. SUS is essential to the acceptance and funding of contemporary medical innovations, such as biomaterials. Standards and technical rules for medical equipment and biomaterials are established in Brazil by the National Institute of Metrology, Quality, and Technology (INMETRO). Companies looking to market medical devices and biomaterials in Brazil frequently need to have INMETRO certifications.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Biomaterials in Healthcare Market Segmentation

By Type (Revenue, USD Billion):

Based on type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. The Metallic Biomaterials segment accounted for the largest share of the Brazil market in 2019. The growing geriatric population Brazilly is expected to drive growth for this segment.

Metallic Biomaterials
- Stainless Steel
- Titanium & Titanium Alloys
- Cobalt-Chrome Alloys
- Gold
- Silver
- Magnesium
Polymeric Biomaterials
- Polymethylmethacrylate
- Polyethylene
- Polyester
- Silicone Rubber
- Nylon
- Polyetheretherketone
- Other Polymeric Biomaterials
Ceramics
- Calcium Phosphate
- Zirconia
- Aluminum Oxide
- Calcium Sulfate
- Carbon
- Glass
Natural Biomaterials
- Hyaluronic Acid
- Collagen
- Gelatin
- Fibrin
- Cellulose
- Chitin
- Alginates
- Silk

By Application (Revenue, USD Billion):

The cardiovascular, orthopaedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology, neurological/CNS, and other applications segments are made up of the biomaterials market. The market category for wound healing is anticipated to have the highest CAGR in 2019. The market will increase as a result of factors including expanding healthcare infrastructure, a large population pool, a rising diabetic population, and rising healthcare spending. Surgical Guides

Cardiovascular
- Catheters
- Stents
- Implantable Cardiac Defibrillators
- Pacemakers
- Sensors
- Heart Valves
- Vascular Grafts
- Guidewires
- Others
Orthopedic
- Joint Replacement
  - Knee Replacement
  - Hip Replacement
  - Shoulder Replacement
  - Others
- Viscosupplementation
- Bioresorbable Tissue Fixation
- Spine?
  - Spinal Fusion Surgeries
  - Minimally Invasive Fusion Surgeries
  - Motion Preservation & Dynamic Stabilization Surgeries
    - Pedicle-Based Rod Systems
    - Interspinous Spacers
    - Artificial Discs
- Fracture Fixation Devices
  - Bone Plates
  - Screws
  - Pins
  - Rods
  - Wires
- Synthetics Bone Grafts
Ophthalmology
- Contact Lenses
  - Intraocular Lenses
  - Functional Replacement of Ocular Tissues
  - Synthetic Corneas
  - Others
Dental
- Dental Implants
- Dental Bone Grafts & Substitutes
- Dental Membranes
- Tissue Regeneration
Plastic Surgery
- Soft-Tissue Fillers
- Craniofacial Surgery
Wound Healing
- Wound Closure Devices
  - Sutures
  - Staples
- Surgical Hemostats
- Internal Tissue Sealants
- Adhesion Barriers
- Hernia Meshes
Tissue Engineering
- Scaffolds for Regenerative Medicine
- Nanomaterials for Biosensing
- Tailoring of Inorganic Nanoparticles
  ?
Neurological/Central Nervous System Applications
- Shunting Systems
- Cortical Neural Prosthetics
- Hydrogel Scaffolds for CNS Repair
- Neural Stem Cell Encapsulation
  ?
Other Applications
- Drug Delivery Systems
- Gastrointestinal Applications
- Bariatric Surgery
- Urinary Applications

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.